Emrich D
Arzneimittelforschung. 1977 Feb;27(2):422-6.
Investigation of the iodine metabolism in man during and after the ingestion of D,L-methyl-3,5,3,5-tetraiodothyronine-ethylester-hydrochloride (etiroxat-hydrochloride, Skleronorm) exhibited the following results: 1. After 20-40 mg of etiroxat the absolute iodine uptake of the thyroid gland was increased 3-7 times. There was indirect evidence that the incretion rate of thyroid hormones did not change. 2. The concentration of total iodine, T4(D), T4(RIA) and T3(RIA) was artificially increased by etiroxat for 2-3 months after cessation of its application. Therefore these parameters do not offer information on the concentration of thyroid hormones in the blood during this period of time. 3. Like other thyroid hormone analogues 40 mg etiroxat daily for 4 weeks blocks the TSH incretion induced by 200 microng TRH up to 1-2 weeks after cessation.
对人体摄入盐酸 D,L-甲基-3,5,3,5-四碘甲状腺原氨酸乙酯(盐酸乙氧噻嗪,硬化平)期间及之后的碘代谢进行研究,结果如下:1. 摄入 20 - 40 毫克乙氧噻嗪后,甲状腺的绝对碘摄取量增加 3 - 7 倍。有间接证据表明甲状腺激素的分泌速率未发生变化。2. 停用乙氧噻嗪后 2 - 3 个月内,乙氧噻嗪使总碘、T4(分光光度法)、T4(放射免疫分析法)和 T3(放射免疫分析法)的浓度人为升高。因此,在此期间这些参数无法提供血液中甲状腺激素浓度的信息。3. 与其他甲状腺激素类似物一样,每天服用 40 毫克乙氧噻嗪,持续 4 周,在停药后长达 1 - 2 周内可抑制由 200 微克促甲状腺激素释放激素诱导的促甲状腺激素分泌。